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Abstract
Chikungunya virus (CHIKV; genus Alphavirus, family Togaviridae) has recently caused sev-
eral major outbreaks affecting millions of people. There are no licensed vaccines or antivi-
rals, and the knowledge of the molecular biology of CHIKV, crucial for development of
efficient antiviral strategies, remains fragmentary. CHIKV has a 12 kb positive-strand RNA
genome, which is translated to yield a nonstructural (ns) or replicase polyprotein. CHIKV
structural proteins are expressed from a subgenomic RNA synthesized in infected cells.
Here we have developed CHIKV trans-replication systems, where replicase expression and
RNA replication are uncoupled. Bacteriophage T7 RNA polymerase or cellular RNA poly-
merase II were used for production of mRNAs for CHIKV ns polyprotein and template
RNAs, which are recognized by CHIKV replicase and encode for reporter proteins. CHIKV
replicase efficiently amplified such RNA templates and synthesized large amounts of sub-
genomic RNA in several cell lines. This system was used to create tagged versions of ns
proteins including nsP1 fused with enhanced green fluorescent protein and nsP4 with an
immunological tag. Analysis of these constructs and a matching set of replicon vectors
revealed that the replicases containing tagged ns proteins were functional and maintained
their subcellular localizations. When cells were co-transfected with constructs expressing
template RNA and wild type or tagged versions of CHIKV replicases, formation of character-
istic replicase complexes (spherules) was observed. Analysis of mutations associated with
noncytotoxic phenotype in CHIKV replicons showed that a low level of RNA replication is
not a pre-requisite for reduced cytotoxicity. The CHIKV trans-replicase does not suffer from
genetic instability and represents an efficient, sensitive and reliable tool for studies of differ-
ent aspects of CHIKV RNA replication process.
Introduction
Chikungunya virus (CHIKV) (genus Alphavirus, family Togaviridae) is a mosquito-transmit-
ted virus and the causative agent of chikungunya fever, which has affected millions during the
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2004–2008 Indian Ocean outbreak, and since 2013 in the Caribbean region and the Americas
[1]. There are no approved vaccines or specific antivirals for treatment of CHIKV infection,
although several active chemical compounds have been reported and some CHIKV vaccine
candidates have entered the early phases of clinical trials [2]. CHIKV has been less studied
than the model alphaviruses Semliki Forest virus (SFV) and Sindbis virus (SINV). In several
aspects, such as the enzymatic functions or structures of virus-encoded proteins, the similari-
ties between these viruses have been experimentally confirmed [3–6]. However, for interactions
with the host, both similarities [7–9] and differences [10,11] have been reported. Hence, knowl-
edge acquired from studies of other Old World alphaviruses does not always apply to CHIKV.
CHIKV has a positive-strand RNA genome of approximately 12 kb in length. The genomic
RNA has a 50 cap0 structure and 30 poly(A) tail and contains two open reading frames (ORF).
In the alphavirus genome, there are four conserved sequence elements (CSEs), three of which
are required for RNA replication: the 50 untranslated region (UTR), a 51-nt replication enhanc-
ing element in the beginning of the first ORF, and the end of the 30 UTR followed by at least 11
adenine residues [12,13]. The fourth CSE represents the core of the subgenomic (SG) pro-
moter, required for synthesis of the mRNA for viral structural proteins [14]. The nonstructural
(ns) proteins of alphaviruses are expressed from the genomic RNA as a precursor termed
P1234 polyprotein, or as a combination of P123 and P1234 polyproteins [15]. The precursors
are absolutely required for proper replicase complex formation [16,17]. The partially processed
intermediate P123 and nsP4 form a short-lived early replicase that synthesizes a genome-
length negative strand [6,18]. Negative-strand synthesis is linked to the formation of mem-
brane invaginations or spherules, which are the physical sites of alphavirus RNA replication
[19]. The complete processing of the ns polyprotein alters the replicase to its late form respon-
sible for synthesizing positive-strand genomic and SG RNAs [16]. For CHIKV, most of the rep-
lication complexes (spherules) are located close to the plasma membrane [10], whereas for SFV
the spherules are predominantly internalized to the surfaces of modified endo- and lysosomal
compartments and form vesicular structures termed type I cytopathic vesicles (CPV) [20].
The alphavirus ns proteins have several known enzymatic functions: nsP1 acts as the viral
RNA capping enzyme [21], nsP2 is an RNA triphosphatase, NTPase, helicase and protease [3],
and nsP4 the core viral RNA-dependent RNA polymerase [22]. A significant amount of each
ns protein is located outside of replicase complexes. Individual nsP1 is mostly attached to the
inner surface of the plasma membrane and has been shown to counter-act the antiviral effects
of tetherin [23]. Individual nsP2 is located both in the nucleus and in the cytoplasm and, for
Old World alphaviruses (CHIKV included), is central for counter-acting host antiviral
responses [24–26] as well as for suppression of cellular transcription and translation [27,28].
nsP3 is known to interact with various cellular proteins and poly(ADP)ribose [5,8,29,30]. Even
nsP4, which is present in infected cells in very low quantities, has been shown to inhibit host
antiviral pathways [11]. The ns proteins have a very low tolerance for modifications of their N-
termini: substitutions, deletions or additions of even a single amino acid residue have been
shown to have serious effects on the functionality of the proteins [3,31–33]. To date, in the con-
text of infectious virus genomes only nsP2 and nsP3 can be engineered to contain large inserts
(such as fluorescent proteins or luciferases) in different positions [25,34–37]. In contrast, nsP4
has only been tagged with small 3xFLAG-tag fused to the C-terminus [38].
During virus replication, the expression of ns proteins is coupled with RNA replication.
This generates a negative feedback loop for mutations reducing RNA replication. As a result,
such mutations are almost always reverted, pseudoreverted and/or compensated by second-site
mutations [31,39–41], excluding the possibility to analyze their direct effect on replicase activ-
ity. In order to enable such studies, replicase production must be uncoupled from RNA replica-
tion. The alphavirus replicases can replicate and transcribe defective interfering RNAs
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generated in infected cells [42] or artificially constructed RNAs such as helper RNAs [43]. This
has allowed construction of trans-replication systems so far described for SINV and SFV.
These systems have been used to study the biogenesis of spherules [44,45] and for analysis of
biological effects of mutations in the ns proteins [19]. Furthermore, SFV trans-replication sys-
tem has uncovered several new biological properties. First, it was found that the size of alpha-
virus spherules is determined by the length of replicating RNA [46]. Second, SFV replicase was
found to generate abundant interferon-inducing RNAs using cellular RNAs as templates [47].
Similar trans-complementation systems have also been successfully used to study the composi-
tion of the replicase complexes of flaviviruses, another group of positive-strand RNA viruses
[48,49].
Here we describe the construction, properties and use of CHIKV trans-replication systems.
These systems were successfully used to develop CHIKV replicases and replicons containing
enhanced green fluorescent protein (EGFP) insertion in nsP1 or with peptide tags attached to
the C-terminus of nsP4. The tagged trans-replicases enabled efficient spherule formation con-
firming that the essential steps associated with RNA replication were correctly reproduced in
this system. The effects of mutations, associated with noncytotoxic phenotype of CHIKV, on
the trans-replicase were similar to those observed in the context of replicons and genomes.
Thus, CHIKV trans-replication system represents a powerful tool applicable for functional
studies of CHIKV nsPs, replicase complexes and virus-host interactions; it should also be use-
ful for detailed analysis of inhibitory properties of compounds affecting CHIKV replication.
Materials and Methods
Cells and media
All cells were grown at 37°C in 5% CO2 atmosphere; 10% fetal bovine serum, 100 U/mL peni-
cillin and 0.1 mg/mL streptomycin were added to growth media. BHK-21 cells (ATCC CCL-
10) were grown in Glasgow's Minimal Essential Medium (GMEM, Gibco) containing 2% tryp-
tose phosphate broth and 200 mMHEPES. BSR T7/5 (hereafter BSR) cells, a derivative of
BHK-21 cells stably expressing T7 RNA polymerase [50], were cultured in the same medium
supplemented with 1 mg/mL of G418 for selection of T7 RNA polymerase expression. Huh7
cells were grown in Dulbecco’s modified Eagle's medium (DMEM, Gibco). COP-5 murine
fibroblasts [51] and U2OS (human bone osteosarcoma, ATCC HTB-96) cells were maintained
in Iscove's Modified Dulbecco's Medium (IMDM, Gibco) containing L-glutamine.
Construction of expression vectors for CHIKV replicase
CHIKV sequences were based on the isolate LR2006 OPY1 representing the East Central South
African genotype. The sequence encoding for ns polyprotein was optimized according to
human codon usage (hereafter this coding sequence is referred to as P1234) and obtained as
synthetic DNA (Genscript, USA; other synthetic DNAs were also obtained from the same com-
pany). A construct, where only 120 codons from the 50 end and 52 codons from the 30 end of
CHIKV ns ORF were to correspond to human codon usage, was made for comparison. It con-
tains native codon usage in 93% of ns polyprotein encoding region and was designated
P1234-NAT.
In order to express ns polyprotein, two different approaches were used. First, expression of
mRNA for ns polyprotein was driven by the RNA polymerase of bacteriophage T7. To achieve
efficient ns polyprotein translation from non-capped transcripts, the P1234 was placed under
control of the internal ribosomal entry site (IRES) of encephalomyocarditis virus (EMCV)
[52]. To increase the stability of mRNAs, the IRES-P1234 cassette was flanked by the 50 and 30
UTRs from mRNA encoding for human beta actin. 60 adenine residues were added to the 30
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end of the construct; this sequence was followed by the antisense strand ribozyme from hepati-
tis delta virus (HDV) and terminator for T7 RNA polymerase. The sequence containing all
these elements was obtained as synthetic DNA and cloned into pUC57Kan plasmid; the final
construct was designated T7-P1234 (Fig 1A). Second, expression of mRNA for ns polyprotein
was triggered by the immediate early promoter of human cytomegalovirus (CMV). In this case,
the P1234 and P1234-NAT were cloned into pMC-gtGTU2 vector (FIT Biotech Plc, Finland)
that contains the CMV promoter, leader sequence from the thymidine kinase of herpes simplex
virus (HSV TK) with an inserted synthetic intron and late polyadenylation signal from simian
virus 40 (SV40). The constructs were designated CMV-P1234 (Fig 1A) and CMV-P1234-NAT.
In addition, the cassette containing the CMV promoter, P1234 and SV40 polyadenylation sig-
nal was inserted into pMC.BESPX minicircle production vector [53] to generate MCC-P1234.
In order to obtain polymerase-inactive forms of CHIKV replicase the catalytic Gly-Asp-Asp
(GDD) motif in nsP4 was changed to Gly-Ala-Ala (GAA) using PCR-based site-directed muta-
genesis. The resulting construct was designated P1234GAA.
Construction of plasmids for expression of template RNAs
Amatching set of plasmids, designed to express template RNAs for CHIKV replicase from T7
and CMV promoter-based vectors, was constructed as follows. All template RNAs were
designed to contain following elements: 1) the full-length 50 UTR of CHIKV followed by the
region encoding for the 77 N-terminal amino acid residues of nsP1 (this region contains the
51-nt CSE); 2) sequence corresponding to the SG promoter and intergenic region of CHIKV
(spanning residues -78 to +69 with respect to the start position of SG RNA); 3) the 30 end (110
residues) of the 30 UTR of CHIKV followed by 60 adenine residues and HDV antisense strand
ribozyme. The elements 1, 2 and 3 were separated from each other by short polylinkers that
were subsequently used for insertion of sequences coding for marker proteins.
For T7 promoter-based system the template RNA cassette was placed between the minimal
(-17/+1) promoter and terminator of T7 RNA polymerase. Sequence containing all the ele-
ments was obtained as synthetic DNA and cloned into pUC57Kan vector. Subsequently, the
sequence encoding for Renilla luciferase (Rluc) was fused with ORF encoding the 77 N-termi-
nal residues of nsP1 and the sequence encoding for Tomato fluorescent marker protein was
inserted under the CHIKV SG promoter; the resulting plasmid was designated T7-Rluc-Tom
(Fig 1B). Alternatively, sequences encoding for firefly luciferase (Fluc) and Gaussia luciferase
(Gluc) were inserted using the same approach, generating T7-Fluc-Gluc (Fig 1B). To obtain
plasmid designated as T7-Rluc-Tom-Vis, the second copy of T7 promoter and sequence
encoding for mCherry marker protein were included into the T7-Rluc-Tom vector (Fig 1B), as
previously described for SFV [19]. For CMV promoter-based system the first residue of tem-
plate RNA was positioned to the start site of CMV promoter; SV40 late polyadenylation
sequence was placed downstream of the cassette for template RNA. The second intron from
the human beta globin gene was inserted after residue 303, according to CHIKV LR2006 OPY1
genome numbering. Sequence containing all these elements was obtained as synthetic DNA
and cloned into pUC57Kan vector. The markers were inserted as described above; resulting
plasmids were designated CMV-Rluc-Tom and CMV-Fluc-Gluc (Fig 1B).
Insertion of EGFP and peptide tags
Polylinker with sequence 50-ACTAGTCTCGAGCCCGGG-30 (sites for SpeI and SmaI under-
lined) was inserted using PCR-based mutagenesis into the following positions of T7-P1234 and
CMV-P1234 plasmids: 1) after codon 492 (site 1A), 497 (site 1B), 516 (site 1C) or 525 (site 1D)
of nsP1; 2) after codon 466 (site 2A) or 618 (site 2B) of nsP2; 3) after codon 383 of nsP3. The
Chikungunya Virus Trans-Replication Systems
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Fig 1. Construction of trans-replication systems. (A) Schematic presentation of T7- and CMV promoter-based expression constructs of CHIKV replicase.
T7—promoter for T7 RNA polymerase; IRES—EMCV IRES; CMV—CMV promoter; LI—HSV TK leader region with an intron. Arrows below the drawings
point to the position of the inactivating GDD to GAAmutation in the catalytic site of nsP4. (B) Schematic presentation of T7—and CMV promoter-based
constructs expressing template RNAs. The 50 and 30 UTRs are from CHIKV; N77—region encoding for the 77 N-terminal amino acid residues of nsP1; SG—
CHIKV SG promoter. The position of the human beta globin intron (hBG), removed by splicing, is marked. For both A and B, the antisense strand ribozyme of
HDV (RZ), T7 transcription terminator and SV40 late polyadenylation region are shown. The drawings are not in scale. (C) U2OS cells were co-transfected
Chikungunya Virus Trans-Replication Systems
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sequence encoding for EGFP flanked with Gly-Gly linkers was fused with adapters containing
sites for SpeI (50 end) and SmaI (30 end) endonucleases, amplified by PCR and inserted into the
positions listed above. The resulting constructs were designated (either CMV- or T7-)
P1E234-A, P1E234-B, P1E234-C, P1E234-D, P12E34-A, P12E34-B, and P123E4. Plasmid
T7-P123E4GAA was obtained from T7-P123E4 by changing the Gly-Asp-Asp motif in nsP4 to
Gly-Ala-Ala. To fuse EGFP to the C-terminus of nsP4 the flexible linker with sequence Ser-
Gly-Gly-Ser-Gly-Gly was added to the N-terminus of EGFP. This fusion was achieved by PCR-
based mutagenesis, giving T7-P1234E and CMV-P1234E.
To insert sequences recognized by commercially available antibodies and/or purification
systems three peptide tags with a similar length were designed: 1) SF-tag consisted of the
sequences of Strep- (bold) and 3xFLAG-tag (underlined): WSHPQFEKMDYKDHDGDYKDHDID
YKDDDDK; 2) HF-tag consisted of HA- (bold) and 3xFLAG-tag (underlined): YPYDVPDYAMD
YKDHDGDYKDHDIDYKDDDDK; 3) HS-tag consisted of two copies of HA-tag (bold) followed
by Strep-tag (underlined): YPYDVPDYAMYPYDVPDYAMWSHPQFEK. To attach these tags to
the C-terminus of nsP4 a flexible linker with sequence Gly-Gly-Gly-Gly-Ser was added to the
N-terminus of the tag. Sequences encoding for such tags were obtained as synthetic DNAs and
fused with the 30 end of the P1234 in T7-P1234 and CMV-P1234 plasmids resulting in (either
CMV- or T7-) P1234SF, P1234HF, and P1234HS expression constructs.
Introduction of point mutations
Point mutations, resulting in the following changes of encoded nsP2 protein, were made in
CMV-P1234 using PCR-based site directed mutagenesis; designations of the constructs are
provided in parentheses: Glu117 to Lys (CMV-P12EK34), Lys192 to Asn (CMV-P12KN34),
insertion of Gly-Glu-Glu-Gly-Ser sequence after amino acid residue 647 (CMV-P125A34) and
Pro718 to Gly (CMV-P12PG34). In addition, two constructs containing nsP2 region harboring
combinations of mutations were made: CMV-P12EKPG34 and CMV-P125APG34.
Construction, rescue and analysis of recombinant replicon vectors and
viruses
pChikRepl (hereafter referred to as Repl-wt), a plasmid containing the cDNA of CHIKV repli-
con vector [54], was used for construction of CHIKV replicons expressing nsP1, nsP2 or nsP3
carrying an EGFP insertion. Briefly, PCR-based mutagenesis was used to insert polylinker (50-
ACTAGTCTCGAGCCCGGG-30) into selected positions of Repl-wt: after codon 516 of nsP1,
after codon 486 of nsP2 or after codon 383 of nsP3; sequence encoding for EGFP was inserted
as described above. The resulting replicons were designated as Repl-1E, Repl-2E and Repl-3E.
To construct CHIKV replicons expressing nsP4 with SF- or HF-tag at its C-terminus the cod-
ing region of nsP4 was fused with that of SF- or HF-tag as described above. In addition, the SG
promoter of CHIKV was inactivated by synonymous changes introduced into the region
encoding for the 27 C-terminal amino acid residues of nsP4. These replicons were designated
Repl-4SF and Repl-4HF. pICRES1-SG-Rluc [8] was used to obtain plasmids containing the
infectious cDNAs of CHIKV expressing nsP4 with SF- or HF-tag at its C-terminus. The coding
regions of SF- or HF-tags were fused to that of nsP4; the native SG promoter was inactivated
by synonymous changes as described above. The expression of the mRNA for structural
with CMV-P1234 + CMV-Fluc-Gluc or CMV-P1234-NAT + CMV-Fluc-Gluc. Gluc activity in the medium was measured at 24 h post transfection. An average
of three independent experiments is shown, error bars represent standard deviation. ** designates p<0.01 (Student’s paired t-test). (D) BSR cells were co-
transfected with T7-P1234 + T7-Fluc-Gluc or CMV-P1234 + CMV-Fluc-Gluc. Aliquots of growth media were collected at the indicated time points and used
for measurement of Gluc activity. Each point represents an average from three parallel experiments; error bars are too small to be shown.
doi:10.1371/journal.pone.0151616.g001
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proteins was maintained due to the preservation of copy of the SG promoter (spanning posi-
tions -78 to +69 with respect to the SG RNA start site) located upstream of the ORF for struc-
tural proteins in the ICRES1-SG-Rluc vector. These recombinant viruses were designated
ICRES-4SF and ICRES-4HF. All these manipulations were done by using synthetic DNA frag-
ments and subcloning procedures.
Plasmids containing the cDNA of CHIKV replicons or genomes were linearized and tran-
scribed in vitro using the mMESSAGE mMACHINE SP6 Transcription kit (Ambion), to
obtain RNAs for transfection of BHK-21 cells. These procedures as well as infectious center
assay (ICA) were performed as previously described [6].
Analysis of CHIKV replicase expression and activity in cell culture
The minicircle forms of CMV-P1234 and MCC-P1234 were obtained as described [53]. These
minicircles and all plasmid DNAs, used for transfection experiments, were purified using
Nucleobond Xtra Midi EF kit (Macherey-Nagel). BHK-21, Huh7, U2OS or BSR cells, grown
on 35 mm plates to 90% confluence, were co-transfected with mixtures consisting of 1 μg of
plasmid encoding CHIKV replicase and 1 μg of plasmid for expression of corresponding RNA
template using Lipofectamine LTX reagent according to the manufacturer's protocols (Invitro-
gen). COP-5 cells were grown and treated similarly and Lipofectamine 2000 (Invitrogen) was
used as transfection reagent. At 18 h post transfection cells were lysed with Renilla luciferase
assay lysis buffer (Promega) and Fluc and Gluc activities were analyzed using the Dual-Lucifer-
ase Reporter Assay kit and Glomax SIS luminometer (Promega); total amount of protein in cell
lysates was measured using Bio-Rad protein assay system according to the manufacturer's pro-
tocols. In some experiments aliquots of growth media were collected at selected time points
and Gluc activity was measured using Renilla Luciferase Assay kit (Promega).
Western blot analysis
Cells were lysed at 24 h (virus/replicon RNA transfected cells) or 18 h (trans-replicase trans-
fected cells) post transfection with SDS gel loading buffer (100 mM Tris-HCl pH 6.8, 4% SDS,
20% glycerol, 200 mM dithiothreitol, and 0.2% bromophenol blue), and proteins were sepa-
rated by 10% SDS-PAGE, transferred to nitrocellulose membranes, and detected using primary
antibodies against CHIKV nsP1, nsP2 (recognizes amino acid residues 1–470), nsP3 (recog-
nizes amino acid residues 1–320) and nsP4 (in-house), FLAG (F1804; Sigma-Aldrich), EGFP
(in-house) or β-actin (sc-47778; Santa Cruz Biotechnology). The membranes were then incu-
bated with appropriate secondary antibodies conjugated to horseradish peroxidase (LabAs Ltd,
Estonia) and proteins were visualized using ECL Immunoblot Detection kit (GE Healthcare).
Northern blot analysis
BSR or U2OS cells were co-transfected with plasmid DNAs coding for CHIKV replicase and
RNA template as described above. At 18 h post transfection, total RNA was extracted using
TRIzol1 reagent (Life Technologies). Equal amounts of total RNAs (1 μg) were denatured for
10 min at 70°C in 2-fold RNA loading dye (Thermo Scientific), cooled on ice and separated on
1% agarose 6% formaldehyde containing denaturing gel using 1xMOPS buffer. RNA was trans-
ferred to a Hybond-N+ filter (GE Healthcare) and fixed using a UV Stratalinker 1800 (Strata-
gene). A digoxigenin (DIG)-labeled RNA, complementary to the last 110 residues of the 30
UTR region of CHIKV genome, was generated using a DIG hybridization kit (Roche) and used
as a probe. Filters were hybridized overnight; blots were washed and developed according to
the manufacturer's protocols (Northern blot with DIG, Roche).
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Confocal microscopy
For immuno-fluorescence imaging, 2x104 U2OS cells were seeded on glass coverslips and incu-
bated overnight at 37°C prior to transfection. For replicon vectors, transfection was performed
using 450 ng of in vitro transcribed Repl-wt, Repl-1E, Repl-2E, Repl-3E or Repl-4SF RNAs. For
trans-replication system, cells were co-transfected using 250 ng of CMV-Rluc-Tom plasmid
and 200 ng of CMV-P1234, CMV-P1E234, CMV-P12E34, CMV-P123E4 or CMV-P1234SF plas-
mids. At 18 h post transfection cells transfected with replicon RNAs or co-transfected with
CMV-P1234+CMV-Rluc-Tom or CMV-P1234SF+CMV-Rluc-Tom were fixed with 4% parafor-
maldehyde buffer, quenched with NH4Cl and permeabilized with 0.1% Triton X-100. dsRNA
and nsP4 with SF-tag were detected using mouse monoclonal antibodies J2 (Scicons, Hungary)
or M2 (Sigma-Aldrich) as primary antibodies respectively and Cy5-conjugated anti-mouse anti-
body (Abcam) as secondary antibody. Samples were mounted with ProLongGold containing
DAPI (Molecular Probes). The cells co-transfected with CMV-Rluc-Tom and CMV-P1E234,
CMV-P12E34 or CMV-P123E4 were fixed with 4% paraformaldehyde buffer and immediately
mounted as described above. In all cases EGFP-tagged ns proteins were detected using EGFP
fluorescence. Imaging was done with Leica TCS SP5 confocal microscope (HCX APO 63x/1.30
Corr glycerol objective) or Leica TCS Sp5II HCS A confocal microscope (HCX PL APO 63x/1.2
W Corr/0.17 CS water objective). The images were analyzed using ImageJ software.
Correlative light and electron microscopy (CLEM)
7.5x104 BSR cells were seeded on 35 mm glass-bottom P35G-2-14-C-Grid dishes (MatTek)
and incubated overnight at 37°C. The cells were then co-transfected using 1.25 μg of plasmids
expressing the CHIKV replicase and 1 μg of T7-Tom-Rluc (for co-transfection with
T7-P123E4GAA a T7-Rluc-Tom-Vis was used instead). At 16 h post transfection the cells were
fixed with 2% glutaraldehyde (Sigma-Aldrich) in 0.1 M sodium-cacodylate buffer (NaCac,
pH7.4) for 20 min at room temperature, washed three times with 0.1 M NaCac buffer and left
in the last wash. The cells were immediately imaged using a Leica TCS Sp5II HCS A confocal
microscope with the HC PL APO 20x/0.7 CS (air) objective lens. Fluorescent and differential
interference contrast (DIC) images of cells containing replicating template RNA (determined
by presence of Tomato marker) were obtained for each sample except for cells transfected
using T7-P123E4GAA plasmid; in this case cells expressing both nsP3-EGFP and mCherry were
selected instead. The gridded dishes were marked in selected areas where positive cells were
spotted during confocal imaging, and prepared for transmission electron microscopy as previ-
ously described [55]. Positive cells, identified during fluorescent and DIC imaging, were located
for each sample using Jeol JEM-1400 transmission electron microscope. Gatan Orius SC 1000B
bottom mounted CCD-camera was used for imaging. All the CLEM experiments were per-
formed twice.
Statistical analysis
Statistical analysis was carried out using original datasets and GraphPad Prism software. Stu-
dent’s paired t-test was used for comparison of two sets of data. To compare means of three or
more samples one-way ANOVA Sidak’s multiple comparisons test was used.
Results
Design of expression constructs for CHIKV replicase and template RNAs
We set out to develop trans-replication systems for CHIKV that could be used in multiple cell
types, to study basic biology of CHIKV as well as virus-host interactions. So far most alphavirus
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trans-replication studies have utilized bacteriophage T7 RNA polymerase to express the repli-
case and its template RNA [19,44–46]. An alternative system based on cellular RNA polymer-
ase II promoter has been described [47] but its properties have not been analyzed in detail.
Therefore it was of interest to perform head-to-head comparison of T7- and RNA polymerase
II promoter-based CHIKV trans-replication systems.
The design of a cassette for T7 promoter-based expression of CHIKV ns polyprotein is
shown in Fig 1A. In order to increase its stability, the expressed mRNA includes 50 and 30 UTR
sequences from human beta actin mRNA. As transcripts made by T7 RNA polymerase lack 50
cap and 3’ poly(A) structures, the EMCV IRES and a poly(A) element of 60 residues were
included. The CMV immediate early promoter was used in vectors relying on use of cellular
RNA polymerase II (Fig 1A), and the necessary transcription elements were provided in the
vector. For both of these replicases, plasmids for expression of template RNAs were con-
structed (Fig 1B). The common elements, required for CHIKV replicase-mediated replication/
transcription of the template RNAs, were: 1) 307 nucleotides from the 50-end of CHIKV
genome; 2) SG promoter; 3) 110 30 nucleotides of CHIKV RNA followed by 60 adenine resi-
dues. The original transcripts from the minimal T7 promoter contain one extra G-residue at
the 50 end. For the CMV promoter, the 50 end of template RNA was positioned precisely at the
start site. To facilitate the nuclear export of CMV promoter derived RNAs, an intron was
inserted into the transcription cassette. The basic template elements 1, 2 and 3 were separated
from each other by polylinkers, which were used for insertion of coding sequences of marker
proteins (Fig 1B).
CHIKV replicase expressed from a codon-optimized sequence is highly
active in trans
The codon usage of alphaviruses represents a compromise between codon usages of their verte-
brate host and mosquito vectors. For SFV, both native and codon-optimized replicase expres-
sion constructs can be used as parts of trans-replication systems [45,47]; however they have
not been compared directly. Thus, it is possible that increased replicase expression, achieved by
codon optimization, may not be optimal in terms of overall RNA replication. On the other
hand, codon optimization enables the removal of sequences that resemble splicing signals,
which might generate aberrant mRNAs from CMV promoter-based vectors. Thus, we com-
pared fully codon optimized CMV-P1234 with CMV-P1234-NAT, which is mostly native
apart from short terminal regions. These constructs, together with the CMV-Fluc-Gluc, were
used to transfect U2OS cells. Both constructs triggered high levels of Gluc expression, but the
reporter activity achieved with CMV-P1234 was significantly (~1.7-fold) higher (Fig 1C).
To further maximize trans-replicase activity, we first compared CMV-P1234, which con-
tains an intron in the leader sequence, with MCC-P1234 lacking introns. In U2OS cells co-
transfected with CMV-P1234 + CMV-Fluc-Gluc or with MCC-P1234 + CMV-Fluc-Gluc the
former combination yielded 3.2–3.8-fold higher Gluc activity. Second, the expression cassettes
in MCC-P1234 and CMV-P1234 vectors can be converted into minicircles devoid of bacterial
DNA; this has been shown to increase expression levels [56,57]. Comparison of standard plas-
mids and the corresponding minicircles in U2OS, BHK21 and COP-5 cells revealed that repli-
case produced fromMCC-P1234 minicircles was 1.7–2.5-fold more effective activator of Gluc
expression. In contrast, for CMV-P1234 the beneficial effect of the minicircle form was mini-
mal (1.3 fold). Based on the combined data from these experiments it was decided to use a
fully codon-optimized sequence encoding for CHIKV replicase (or its mutant forms) in all vec-
tors. For CMV promoter-based system, CHIKV replicase was expressed from standard
CMV-P1234 plasmid.
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Next, the expression kinetics of Gluc reporter in BSR cells transfected with CMV- and T7
promoter-based systems were compared. For both, Gluc activity was high already at 8 h post
transfection and approached a plateau by 16–18 h post transfection (Fig 1D). Based on this, 16
or 18 h post transfection were selected as endpoints for subsequent experiments.
Expression of Fluc and Gluc markers in different cell lines transfected
with CHIKV trans-replicase vectors
The CMV promoter-based trans-replication system was tested in two human (Huh7, U2OS)
and three rodent (BHK-21, BSR, COP-5) cell lines; BSR cells were also co-transfected with
T7-P1234 + T7-Fluc-Gluc. Gluc is encoded by the second ORF of the template RNA (Fig 1B)
and therefore its expression requires the synthesis of SG RNAs. The highest levels of Gluc activ-
ity were observed in BHK-21 and U2OS cells but they were very high also in other cell lines
(Fig 2A), indicating efficient RNA replication/transcription. The background for Gluc,
obtained with an inactive replicase expressed by CMV-P1234GAA or T7-P1234GAA, was low
and generally a 103−105-fold increase was achieved by trans-replication (Fig 2B).
Similarly, high levels of Fluc activities were detected in all the transfected cell lines (Fig 2C).
However, as Fluc is encoded by the first ORF of the template RNA, it can also be expressed in
the absence of active CHIKV replicase. Coherently, a relatively small increase of Fluc activity
was observed for the CMV promoter-based system, when the inactive polymerase was used as
a control (Fig 2C and 2D). In contrast, Fluc expression in BSR cells co-transfected with
T7-P1234GAA + T7-Fluc-Gluc occurred at a low level, whereas co-transfection of BSR cells
with T7-P1234 + T7-Fluc-Gluc resulted in Fluc expression at levels similar to those measured
for the CMV promoter-based system (Fig 2C). Since transcription of T7 promoter containing
plasmids in BSR cells is efficient [19,46] (Fig 3B), the low levels of Fluc in absence of active
CHIKV replicase indicate that such transcripts are poorly translated compared to the tran-
scripts from CMV promoter, likely because they should lack 50 cap structures. Based on this
data U2OS cells were selected as the main cell line for experiments with the CMV promoter-
based trans-replicase system and inactive polymerase controls were included in all subsequent
assays.
CHIKV trans-replication systems amplify the template RNA and
generate large amounts of SG RNA
Next, we directly analyzed the presence of CHIKV ns proteins and positive-strand RNAs to
compare the T7- and CMV promoter-based systems. CHIKV ns proteins were synthesized
both in CMV-P1234 and T7-P1234 transfected cells. The GAA mutation in nsP4 had no nega-
tive effect on ns protein expression (Fig 3A). No ns polyproteins were detected indicating that
by 18 h post transfection the replicase expression had ceased or that the ns polyproteins were
processed too fast to allow their detection by western blotting. The levels of ns proteins
depended both on the type of cells and on the design of the trans-replication system. In BSR
cells the maximal levels of ns protein expression were observed for T7 promoter-based vectors
(Fig 3A). This finding could explain why the T7 promoter-based system was generally a more
efficient activator of Gluc expression in BSR cells (Fig 2A). However, in some experiments
such a difference was not observed (Fig 1D). Furthermore, the levels of CHIKV ns proteins in
U2OS cells were clearly lower than in BSR cells (Fig 3A), and yet the expression of Gluc
occurred at comparable or even slightly higher level (Fig 2A).
The analysis of viral RNAs revealed that the levels of full-length (“genomic”) transcripts
were greatly boosted by active CHIKV replicases (Fig 3B). The original transcripts from
CMV-Fluc-Gluc were present at very low levels and undetectable using normal exposure. High
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Fluc activities in the cells co-transfected with CMV-P1234GAA + CMV-Fluc-Gluc (Fig 2C)
indicate that these RNAs were, however, very actively translated. In U2OS cells, the relatively
small amount of ns proteins (Fig 3A) and low levels of CMV promoter-derived template RNAs
did not seem to limit RNA replication (Fig 3B). In the absence of active replicase the template
RNA levels were the highest in BSR cells transfected with T7 promoter-based vectors (Fig 3B).
However, also in this case the active replicase caused clear amplification of genomic RNAs and
synthesis of large amounts of SG RNA (Fig 3B). Overall, the highest SG RNA levels were seen
in U2OS cells (Fig 3B). As the observed SG RNA levels correlated with the Gluc activities in
U2OS and BSR cells (Fig 2A) the Gluc activity serves as a good indicator of the efficiency of SG
Fig 2. Expression of marker proteins in cell lines transfected with trans-replicase vectors.Huh7, U2OS, COP-5, BHK-21 and BSR cells were co-
transfected with CMV-P1234 + CMV-Fluc-Gluc (marked as CMV); BSR cells were also co-transfected with T7-P1234 + T7-FLuc-Gluc (marked as T7).
Control cells were transfected with T7-FLuc-Gluc or CMV-Fluc-Gluc together with corresponding plasmid encoding for inactive replicase. Cells were lysed at
18 h post transfection. Gluc (A) and Fluc (C) activities (RLU—relative light unit), normalized to the total protein content in the lysate, are shown. Each column
represents an average of three independent experiments; error bars represent standard deviation. All differences between P1234GAA (empty columns) and
P1234 (grey columns) were highly significant (p<<0.001); in C ** designates p<0.01 and *** designates p<0.001 (one-way ANOVA Sidak’s multiple
comparisons test). (B) and (D). The reporter activities generated by the active replicase were normalized to those measured with the inactive controls.
doi:10.1371/journal.pone.0151616.g002
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RNA transcription for both CMV and T7 promoter-based trans-replication systems. In con-
trast, Fluc activity can serve as an indicator of template RNA replication only for the T7 pro-
moter-based trans-replication system. Therefore hereafter the efficiencies of trans-replicases
are presented as the normalized Fluc (for template RNA replication) or Gluc (for SG RNA syn-
thesis) activities.
Fig 3. Expression of ns proteins and replication/transcription of template RNA by trans-replication systems. U2OS and BSR cells were co-
transfected with CMV-P1234 + CMV-Fluc-Gluc or CMV-P1234GAA + CMV-Fluc-Gluc (CMV). In addition, BSR cells were transfected with T7-P1234
+ T7-Fluc-Gluc or T7-P1234GAA + T7-Fluc-Gluc (T7); mock-transfected cells were used as controls. Samples were collected at 18 h post transfection. The
experiment was repeated three times with similar results; data from one experiment is shown. (A) Proteins in cell lysates were analyzed by western blotting
using polyclonal antibodies against nsP1, nsP2, nsP3 and nsP4. Antibody against beta actin was used to detect loading control. Sections of gels
corresponding to these proteins are shown; appropriate molecular mass markers are indicated on the left. (B) RNA was analyzed by northern blotting using a
probe complementary to the 30 UTR of CHIKV. “Genomic” designates the full-length template RNA; note that this RNA is also synthesized by T7 RNA
polymerase or cellular RNA polymerase II and is therefore also detectable in the presence of inactive replicases (P1234GAA). “Subgenomic” designates RNA
synthesized by CHIKV replicase using the SG promoter.
doi:10.1371/journal.pone.0151616.g003
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CHIKV ns proteins, produced by trans-replicase vectors, can be tagged
using EGFP or epitope tags
Recombinant alphaviruses carrying immunological, affinity, luciferase or fluorescent tags in
their ns proteins have been used to study various aspects of the viral life cycle [20,37,38,58,59].
The C-terminal region of nsP3 can accommodate tags in various positions; positions suitable
for tag insertion have also been revealed in nsP2 but not in nsP1. SFV or CHIKV with addition
of EGFP to the C-terminus of nsP4 are genetically highly unstable and lose inserted EGFP
marker (Merits at al., unpublished data). In a trans-replication system, however, changes intro-
duced into the replicase proteins cannot be reverted. This should offer possibilities to study the
effects of tags and other modifications in ns proteins on the RNA replication as well as on the
localization and other functions of these proteins.
EGFP was inserted into four different positions located in the C-terminal region of nsP1,
into two positions in nsP2 corresponding to those previously used to tag SINV nsP2 [37], into
the previously used position in nsP3 [60] and, via short flexible linker, to the C-terminus of
nsP4 (Fig 4A). Corresponding T7 promoter-based expression constructs were transfected to
BSR cells together with the T7-Fluc-Gluc. Based on Fluc and Gluc activities, it was concluded
that the EGFP insertion in nsP3 (P123E4) had little to no effect on the template RNA replica-
tion/transcription (Fig 4B). The same was observed for EGFP inserted after amino acid residue
466 of nsP2 (P12E34-A); in contrast insertion of EGFP after amino acid residue 618 of nsP2
(P12E34-B) reduced template RNA replication and transcription at least 100-fold (Fig 4B). The
effect of EGFP insertion into nsP1 also strongly depended on the exact position of insertion.
Insertions after residues 492 (P1E234-A), 497 (P1E234-B) or 525 (P1E234-D) resulted in promi-
nent reduction of template RNA replication and transcription (Fig 4B). In contrast, insertion
after residue 516 (P1E234-C) caused milder effects, revealing this to be the most suitable site
for EGFP insertion. EGFP fused to the C-terminus of nsP4 allowed for RNA replication and
transcription, confirming that nsP4 with such tag was functional. However, the activity of
nsP4-EGFP fusion protein was severely compromised: replicase harboring such mutation
yielded no more than 1% template RNA replication or transcription compared to wild type
replicase (Fig 4B). All these findings were confirmed with CMV promoter-based trans-replica-
tion systems in U2OS cells (Fig 4C), showing that the effects were cell-type independent. For
nsP1 and nsP2, we selected the most active tagged trans-replicases (hereafter referred to as
P1E234 and P12E34) for further characterization.
The available antibodies against nsP4 have low efficiency and specificity (note an unspecific
band for mock-transfected cells in Fig 3A); coupled with the low abundance it makes compro-
mises detection of nsP4. Additional attempts for tagging of nsP4 with fluorescent proteins
were therefore made; unfortunately these too failed to produce satisfactory results. However, it
was observed that nsP4 does tolerate short (up to 40 amino acid residues) extensions at its C-
terminus. Therefore SF-, HF- and HS-tags of similar (28–32 amino acid residues) length were
designed, fused to the C-terminus of nsP4 (Fig 4A) and tested in the context of trans-replica-
tion systems. Transfection of BSR cells with the T7 promoter-based vectors revealed that the
negative effect of the SF-tag on template RNA replication/transcription was the smallest. The
HF-tag greatly reduced the activity of the CHIKV trans-replication system, and the HS-tag
reduced replication of template RNA to a background level (Fig 4B). In U2OS cells transfected
with the CMV promoter-based system these effects followed the same pattern, though negative
effects of HF- and HS-tags were somewhat less prominent (Fig 4C).
Finally, we wanted to confirm that the tagged trans-replicase vectors indeed expressed the
correct fusion proteins. For this BSR cells were transfected with T7-P1E234, T7-P12E34,
T7-P123E4, T7-1234SF, T7-P1234GAA or T7-P1234 vectors; the corresponding set of CMV
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Fig 4. Tagging of replicase expression constructs. (A) Positions used for EGFP insertion are indicted by arrows with numbers corresponding to the amino
acid residue after which the EGFP was inserted. Tags fused to the C-terminus of nsP4 are designated as follows: E—EGFP; HF—HA-tag+3xFLAG-tag; SF
—Strep-tag+3xFLAG-tag; HS—two copies of HA-tag+Strep-tag. (B) BSR cells were co-transfected with T7-Fluc-Gluc and T7-P1234 or plasmids expressing
tagged versions of ns polyprotein (indicated below the graphs). Cells co-transfected with T7-Fluc-Gluc + T7-P1234GAA served as controls. At 18 h post
transfection cells were lysed, and activities of Fluc (left panel) and Gluc (right panel) in the cell lysates were measured. The activities of reporters were
normalized to those measured in control cells. Data from one independent reproducible experiment out of three is shown. (C) U2OS cells were co-transfected
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promoter-based vectors was used to transfect U2OS cells. Western blot analysis revealed an
identical set of ns proteins expressed in both cell types. The presence of EGFP in nsP1, nsP2 or
nsP3 was evident from the increased sizes of the tagged proteins and by their detection with an
anti-EGFP antibody. Similarly, fusion of the SF-tag to nsP4 was detected both by the slightly
increased size of the nsP4 and by its recognition with an anti-FLAG antibody (Fig 4D).
Insertions tested using the trans-replication system can be transferred to
replicon vectors and infectious genomes
First we constructed CHIKV replicon vectors, where the markers were inserted in the same
way as in trans-replicases (Fig 5A). Transfection of BHK-21 cells with in vitro transcribed
RNAs of Repl-1E, Repl-2E, Repl-3E, Repl-4SF and Repl-wt resulted in prominent cytotoxic
effects indicating efficient RNA replication. In contrast, no such effect was observed for cells
transfected with RNAs corresponding to Repl-4HF. Cells transfected with RNAs of Repl-1E,
Repl-2E and Repl-3E also displayed green fluorescence (Fig 6). The analysis of proteins,
expressed from Repl-1E, Repl-2E, Repl-3E, Repl-4SF and Repl-wt revealed a picture very similar
to that observed for the corresponding trans-replicase constructs (compare Figs 5B and 4D).
Thus, all these replicons expressed the expected set of ns proteins. Taken together, these experi-
ments revealed that designs developed and evaluated with trans-replication systems could be
applied to replicating RNAs.
Next, the effects of C-terminal tags in nsP4 were analyzed in the context of full-length
CHIKV genome. It was observed that the rescue efficiency of ICRES-4SF (~4.6x104 plaque
forming units (PFU)/μg RNA in BHK-21 cells) was only one-log lower than that of ICRES-wt
(~5.5x105 PFU/μg RNA). In contrast, the rescue of ICRES-4HF occurred at a much lower level
(~9.1x102 PFU/μg RNA). However, the progeny of ICRES-4HF reached a titer of 2.0x108 PFU/
mL; even higher than other viruses used in this experiment (1.2x108 PFU/mL for ICRES-wt
and 6.3x107 PFU/mL for ICRES-4SF). Western blot analysis of infected cells revealed that all
three viruses expressed ns proteins roughly at the same level (as an example, nsP2 is shown in
Fig 5D). However, only ICRES-4SF but not ICRES-4HF expressed the tagged version of nsP4
(Fig 5D) confirming that the latter virus was genetically unstable and that an overwhelming
majority of its progeny had lost the inserted tag (Fig 5E). When the same experiment was per-
formed using replicon vectors it was observed that only Repl-wt and Repl-4SF replicated at a
high level and produced large amounts of ns proteins. As expected, Repl-4SF also expressed the
tagged form of nsP4. In contrast, expression of nsP2 and tagged nsP4 in Repl-4HF transfected
cells occurred at a very low level (Fig 5E). This data unequivocally demonstrates that HF-tag at
the C-terminus of nsP4 seriously inhibits virus genome replication.
Interestingly, an additional protein recognized by anti-nsP1 antibodies, most likely originat-
ing from replicon RNAs that had lost the inserted marker protein encoding sequence, was also
revealed for Repl-1E transfected cells; additional bands, most likely also originating from the
instability of Repl-1E replicon, were also detected with nsP2 and nsP4 antibodies (Fig 5B). It
could be noted that the replication of template RNA in the cells transfected with T7-P1E234-C
was less efficient than in cells transfected with T7-P12E34, T7-P123E4 or T7-P1234SF but more
efficient than in cells transfected with T7-P1234HF (Fig 4B, left panel). Thus, there is a clear
correlation between the activities of mutant forms of trans-replicase and the stability of RNA
with CMV-Fluc-Gluc and CMV-P1234 or plasmids expressing tagged versions of ns polyprotein. The data is presented as in B. (D) BSR (left) and U2OS
(right) cells were used to detect expression of ns proteins from T7- and CMV promoter-based vectors, respectively. The constructs used are indicated at the
top. Analysis was performed as described for Fig 3A; additionally anti-EGFP and anti-FLAG antibodies were also used for detection of proteins carrying
corresponding tags. Data from one independent reproducible experiment out of two is shown.
doi:10.1371/journal.pone.0151616.g004
Chikungunya Virus Trans-Replication Systems
PLOSONE | DOI:10.1371/journal.pone.0151616 March 10, 2016 15 / 27
Fig 5. Tagging of ns proteins in the context of CHIKV replicons and genomes. (A) Drawing above: sites used for insertion of EGFP into nsP1, nsP2 and
nsP3 of CHIKV replicon are shown as in Fig 4A. SG—SG promoter (arrow designates the transcription start site), SP6 –bacteriophage SP6 RNA polymerase
promoter. Drawing below: CHIKV replicon encoding for nsP4 with SF- or HF-tag (black) attached to its C-terminus. In these constructs the SG promoter was
inactivated by synonymous changes (SC). (B) BHK-21 cells were transfected with the indicated in vitro synthesized replicon RNAs. Cells were lysed upon
detection of prominent cytopathic effects, and the proteins expressed were analyzed as described for Fig 4D. Data from one independent reproducible
experiment out of two is shown.(C) Schematic representation of genomes of wild type CHIKV (ICRES-wt) and recombinant viruses encoding for nsP4 with
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tags at the C-terminus of the protein. Designations are the same as on panel A. (D) BHK-21 cells were transfected with in vitro synthesized ICRES-4SF,
ICRES-4HF and ICRES-wt RNAs; mock-transfected cells were used as control. Transfected cells were lysed upon detection of prominent cytopathic effects.
nsP2 was detected with a corresponding polyclonal antibody and tagged nsP4 was detected with a monoclonal antibody against the FLAG-tag. Data from
one independent reproducible experiment out of two is shown.(E) BHK-21 cells were transfected with in vitro synthesized Repl-4SF, Repl-4HF and Repl-wt
RNAs and analyzed as described above. Data from one independent reproducible experiment out of two is shown.
doi:10.1371/journal.pone.0151616.g005
Fig 6. Localization of tagged ns proteins and dsRNA in cells transfected with replicon RNAs or with the corresponding trans-replicase constructs.
U2OS cells were transfected with in vitro synthesized replicon RNAs (A-F), co-transfected with CMV promoter-based replicase and CMV-Rluc-Tom plasmids
(H-K) or mock-transfected (G, L). The localization of nsPs (shown in green; with exceptions of panels E and K detected using EGFP fluorescence) and
dsRNAs (panels A-D, F; shown in magenta) was analyzed at 18 h post transfection using immunofluorescence microscopy; nuclei were counter-stained with
DAPI. Cells characteristic for each construct are shown on the panels. (A) Repl-wt, (B) Repl-1E, (C) Repl-2E, (D) Repl-3E transfected cells; Repl-4SF
transfected cells stained with monoclonal antibodies against FLAG-tag (E) or dsRNA (F). (G)Mock control. (H) CMV-P1E234 + CMV-Rluc-Tom, (I)
CMV-P12E34 + CMV-Rluc-Tom, (J) CMV-P123E4 + CMV-Rluc-Tom, (K) CMV-P1234SF + CMV-Rluc-Tom transfected cell. (L)Mock control. Cells shown on
panels H-K were positive for Tomato fluorescence.
doi:10.1371/journal.pone.0151616.g006
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genomes harboring the same mutations. Furthermore, these findings also highlight one of the
main benefits of the trans-replication system: the achievement of the genetic stability of muta-
tions in the replicase.
Visualization of CHIKV ns proteins expressed from tagged replicons and
trans-replicase vectors
The localization of tagged ns proteins was analyzed using U2OS cells. First, cells were trans-
fected with in vitro transcribed replicon RNAs and analyzed at 18 h post transfection (Fig 6A–
6F); mock-transfected cells were used as controls (Fig 6G). Staining with antibody against
dsRNA revealed that RNA replication occurs predominantly at the plasma membrane both in
the Repl-wt (Fig 6A) and tagged replicons (Fig 6B–6D). EGFP-tagged nsP1 was detected at the
plasma membrane and showed co-localization with dsRNA (Fig 6B). EGFP-tagged nsP2 was
mostly detected in the nucleus (Fig 6C) whereas in Repl-3E transfected cells nsP3-EGFP was
found to form large clusters in the cytoplasm (Fig 6D). In cells transfected with Repl-4SF, nsP4
visualized with anti-FLAG antibodies was mostly localized diffusely in the cytoplasm (Fig 6E);
the RNA replication, however, occurred, as in other replicon RNA transfected cells, at the
plasma membrane (Fig 6F).
Next, cells were transfected with the trans-replication system (Fig 6H–6K) or mock-trans-
fected (Fig 6L). The trans-replication system consists of two plasmids that were not always co-
delivered into the same cell. Therefore, the CMV-Rluc-Tomato template, expressing Tomato
reporter protein via replicase-generated SG RNA, was used to identify cells positive for RNA
replication that were subsequently used for imaging. It was found that tagged trans-replicase
produced fusion proteins localized in the same cellular compartments as their counterparts
produced by replicon vectors: nsP1-EGFP localized near the plasma membrane (Fig 6H),
nsP2-EGFP was observed mostly in the nucleus (Fig 6I), nsP3-EGFP formed aggregates in the
cytoplasm (Fig 6J) and nsP4 expressed from CMV-P1234SF was rather evenly distributed in the
cytoplasm (Fig 6K). Similar localization of dsRNA and tagged ns proteins was observed in
other cell lines transfected using plasmids of CMV promoter-based trans-replicase and in BSR
cells transfected using the T7 promoter-based system. Taken together, the localization of
tagged ns proteins expressed from CHIKV replicons or by trans-replication system was similar
to that previously reported for their non-tagged counterparts [8].
CHIKV trans-replication system generates spherules
To analyze spherule formation using CLEM, BSR cells were co-transfected with T7-Rluc-Tom
and T7-P1234, T7-P1E234, T7-P12E34, T7-P123E4 or T7-P1234SF. Cells positive for RNA rep-
lication were identified as described above and further processed for examination using a trans-
mission electron microscope. Spherules were seen abundantly in all cells where RNA
replication occurred and had similar appearance to the spherules formed by SFV trans-repli-
case [45]; no detectable changes were caused by the presence of the tags. For example, in cells
transfected with T7-P12E34, spherules were observed on the plasma membrane (Fig 7A) and
more rarely in CPVs (Fig 7B). The spherules had a characteristic appearance and a ‘neck’ struc-
ture that projected towards the cytoplasm; the electron-dense region inside the spherules (Fig
7C) most likely corresponds to the RNA replication intermediate.
To analyze the requirement of RNA replication for spherule formation, BSR cells were also
co-transfected with T7-P123E4GAA + T7-Rluc-Tom-Vis. The presence of ns proteins produced
from T7-P123E4GAA was visualized by nsP3-EGFP fluorescence. The presence of T7-Rluc-
Tom-Vis in the same cells was confirmed by fluorescence of mCherry that is expressed inde-
pendent of RNA replication (Fig 1B). Consistent with previous observations made for SFV
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trans-replicase [45] no (Fig 7D) or only few spherule-like structures were observed in these
cells. The scarcity of these spherule-like structures led to the conclusion that the formation of
true spherules is dependent on RNA replication.
Analyzing the effects of mutations associated with noncytotoxic
phenotype
Mutations in the C-terminal region of nsP2 have been shown to reduce the cytotoxicity of
alphavirus replicon vectors [25,61,62]. A prominent mutation involved in this phenotype
changes Pro718 to Gly (PG). However, the PG mutation alone does not render CHIKV repli-
cons noncytotoxic; for this a combination with either Glu117 to Lys (EK) substitution or with
insertion of five amino acids after residue 647 of nsP2 (5A) is required [6,63]. These mutations,
as well as Lys192 to Asn (KN) substitution which completely blocks the NTPase activity of
CHIKV nsP2 [3], were introduced into CMV-P1234 (Fig 8A) and their effects on the activity
of CHIKV trans-replicase were analyzed in U2OS cells.
Mutations associated with noncytotoxic properties of nsP2 inhibit its ability to induce shut-
down of RNA polymerase II mediated transcription [28]. Thus, these mutations may increase
the expression of ns proteins in cells transfected with CMV promoter-based trans-replicase
vectors. To take this effect into account the ns protein expression was analyzed using Western
blotting. From the nsP2 mutations only EK (P12EK34) had no apparent effect on the ns protein
levels (Fig 8B). KN mutation (P12KN34) resulted in increased expression of all ns proteins (Fig
8B), most likely because a functional helicase/NTPase is essential for cytotoxicity and
Fig 7. Visualization of spherules in the cells transfected with trans-replicase vectors. BSR cells were
co-transfected with T7-Rluc-Tom + T7-P12E34 (A, B), T7-Rluc-Tom + T7-P1234 (C) or T7-Rluc-Tom-Vis +
T7-P123E4GAA (D) plasmids. Cells were fixed and analyzed using CLEM at 16 h post transfection. Spherules
(indicated by arrows) were detected in all cells where replication of template RNA was initiated (identified by
Tomato fluorescence). Characteristic EM images are shown in panels A-C. No spherules were detected in
cells co-transfected with T7-Rluc-Tom-Vis+T7-P123E4GAA.
doi:10.1371/journal.pone.0151616.g007
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Fig 8. Functional analysis of mutations in nsP2 using CHIKV trans-replication system. U2OS cells were co-transfected with CMV-Fluc-Gluc and
CMV-P1234 or plasmids expressing mutant versions of ns polyprotein. Cells co-transfected with CMV-Fluc-Gluc + CMV-P1234GAA served as controls. Cells
and media were harvested at 18 h post transfection.(A) Location of mutations in the coding region of CMV-P1234. (B) Expression of ns proteins from
CMV-P1234 and its mutant variants (indicated above the graph) was analyzed as described for Fig 3A. (C) Activities of Gluc in the growth media were
measured and normalized to those measured for control cells. Data from one out of four reproducible independent experiments is shown.
doi:10.1371/journal.pone.0151616.g008
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nsP2-mediated degradation of Rpb1 [28]. A similar effect was also caused by PG mutation
alone (P12PG34) or in combination with EK mutation (P12EKPG34) (Fig 8B); these effects cor-
relate with reduced cytotoxicity of CHIKV replicons harboring the PG mutation [63]. Similar,
albeit less prominent, effect was also observed for 5A mutation (P125A34); again this is coher-
ent with reduced cytotoxicity of corresponding replicons [6].
It was observed that despite elevated expression of ns proteins Gluc expression in the cells
co-transfected with CMV-P12KN34 + CMV-Fluc-Gluc did not exceed background levels (Fig
8C). This indicates that the NTPase, helicase and/or RNA triphosphatase activities, all fueled
by the affected active site, were crucial for CHIKV replicase function. This finding is also in
agreement with results obtained using SFV genomes [64] and trans-replication systems [19].
PG substitution had no negative effect on the activity of CHIKV trans-replication system (Fig
8C). Thus, defects in protease, NTPase and RNA helicase activities, that have been observed for
recombinant nsP2 harboring the corresponding mutation in cell-free assays [6], were not
detected in a cellular environment. Alternatively, the negative effect of PG substitution may,
fully or partially, be compensated by elevated expression levels of ns proteins (Fig 8B). How-
ever, this would seem unlikely as elevated ns proteins levels do not necessarily result in more
efficient RNA replication (Fig 3). The levels of Gluc expression in cells co-transfected with
CMV-Fluc-Gluc and CMV-P12EK34 or CMV-P12EKPG34 were below 0.5% of that observed for
CMV-Fluc-Gluc + CMV-P1234 co-transfected cells (Fig 8C). This correlates with the
extremely low replication of the corresponding replicon RNAs [6]. Combined with the lack of
effect on ns protein expression (Fig 8B) these findings suggested that the noncytotoxic pheno-
type of replicons harboring EK mutation most likely represents a consequence of a severe
defect in RNA replication, which, in turn, leads to drastically diminished nsP2 levels [6].
Restoring the ns protein levels in the trans-replication system (Fig 8B) could not compensate
for this replication defect. Importantly, CHIKV genomes harboring EK or EKPG mutations
also have low infectivity and undergo reversions [6] e.g. display phenotype very similar to that
of ICRES-4HF. In contrast, the 5A mutation reduced Gluc expression by CHIKV trans-replica-
tion system only ~2-fold (Fig 8C). CMV-P125APG34, harboring a combination of mutations
associated with the noncytotoxic phenotype of CHIKV replicon, was a ~5-fold less efficient
inducer of Gluc expression than CMV-P1234 (Fig 8C). This confirmed that the PG and 5A
mutations affect each other; accordingly their combination leads to a phenotype different from
that caused by either mutation individually [6]. Most importantly, this data indicates that
severe reduction of RNA replication (such as caused by EK or EKPG mutations) is not required
to generate noncytotoxic CHIKV replicons. Taken together, the results obtained using CHIKV
trans-replication system complemented and supported previous findings. Thus, the trans-rep-
lication system is a sensitive and reliable instrument in the functional analysis of replicase
mutations.
Discussion
Here we report the construction, properties and use of CHIKV trans-replication systems.
These systems were designed to be robust, highly efficient/sensitive and easy to use. For this
purpose template RNAs expressing Fluc and, via SG RNA synthesis, Gluc reporter proteins
were constructed. Due to very low background levels, we saw a great boost in Gluc activity
both by CMV- and T7 promoter-based trans-replicases (Fig 2) with an excellent correlation
between Gluc activities and levels of SG RNAs in transfected cells (Figs 2A and 3B). Expression
of the first reporter protein (generally Fluc; Figs 2C and 4B) was clearly boosted in the case of
T7 promoter-based CHIKV trans-replicase (Fig 2C and 2D); as previously observed for SFV
trans-replicase [19]. Due to high background levels, only moderate boost in the expression of
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Fluc by the CMV promoter-based trans-replicase was observed (Fig 2C and 2D). Nevertheless,
the replicase produced from the CMV promoter-based vector caused equally, if not more,
prominent amplification of template RNA (Fig 3B).
High efficiency, sensitivity and reproducibility of the trans-replicase are pre-requisites for
its use in the functional analysis of mutations seriously impairing replicase activity. This is
especially important because these are the very mutations that are unstable in the context of
replicating RNA genomes. It was observed that the expression of ns proteins at maximal possi-
ble levels was not required for the highest activities of the trans-replication system (Fig 3): once
very high levels of SG RNA (and Gluc reporter) expression were achieved, additional boosting
of replicase expression resulted in rather small (if any) further increase of RNA synthesis. The
most likely reason behind this phenomenon is negative feedback as increased levels of nsP2 are
known to alter the ns polyprotein processing pathway [65], thus limiting the number of active
replicase complexes per cell. The maximal activities of trans-replicases depended also on the
cell type (Figs 2 and 3); possibly because of differences in cell size, different availability of essen-
tial host factors and/or due to the ability of the host cells to affect the stability of replicase com-
plexes [66]. In order to retain the sensitivity of the assay, setups that were highly efficient but
not over-saturated were used: most commonly U2OS cells, CMV-P1234 (or its derivatives) as
standard plasmid and CMV-Fluc-Gluc as the source of template RNA.
The high sensitivity of the system enabled us to distinguish lethal mutations from those hav-
ing a strong negative impact on CHIKV replicase activity. Thus, only replicases harboring
mutations in the active sites of nsP4 polymerase (P1234GAA) or nsP2 NTPase/triphosphatase/
helicase (P12KN34) were unable to replicate/transcribe the template RNA (Figs 3B and 8C). A
number of mutations caused severe reduction, but did not abolish replicase activity (Figs 4B,
4C and 8C). It was directly shown either in this study (P1234HF; Fig 5D) or known from previ-
ous studies (P12EK34, P12 EKPG34 [6]) that viruses harboring the corresponding mutations
were genetically too unstable to allow any functional studies. This could also be extrapolated to
mutations present in P1E234-A, P1E234-B, P1E234-D, P1234E and P1234HS (Fig 4B and 4C):
their impact on CHIKV replicase activity was too prominent to allow the corresponding
viruses to be genetically stable. There is likely to be a threshold level of replicase activity, neces-
sary for the genetic stability of mutant RNA genomes. Based on the mild instability of Repl-1E
(Fig 5B) and moderately compromised replicase activity of T7-P1E234-C (Fig 4) this mutant is
close to such threshold. Indeed, we have observed that virus genomes harboring the same
mutation could efficiently be rescued and propagated but were not stable enough to allow mul-
tiple in vitro passages.
The CHIKV trans-replication systems can be used for multiple applications. It was shown
that the phenotypes, caused by the mutations studied in the context of CHIKV replicons and
genomes [6,63], were reproduced in the trans-replication system (Fig 8). As any defect in virus
replicase proteins can cause adaptations and/or reversions, a genetically stable trans-replication
system is clearly superior for estimating the direct consequences of such defects on the func-
tionality of the replicase. The tagging of ns proteins in the trans-replication system also resulted
in several intriguing questions regarding the functions of the C-terminal regions of nsP1 and
nsP4. The EGFP-tag was reasonably well tolerated in one specific position of nsP1 but not in
nearby positions; nsP4 apparently did not tolerate the HA-tag at its C-terminus (Fig 4). These
aspects represent topics for independent studies that can provide new and important informa-
tion regarding the assembly and function of CHIKV replicase.
The use of COP-5 cells having an intact type-I interferon system was crucial for the discov-
ery of a new function of the SFV replicase in eliciting an antiviral response [47]. The CMV pro-
moter-based version of CHIKV trans-replication system works well in these cells (Fig 2). Thus,
activities of the replicases from two different alphaviruses can now be directly compared and
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the molecular basis of the ability of SFV replicase to synthesize interferon-inducing dsRNAs
using cellular templates can be revealed. Furthermore, although the wild type CHIKV trans-
replicase performed rather similarly in all the tested cell lines (Fig 2), this is not necessarily the
case for its mutant forms. This provides an opportunity for detailed analysis of host-specific
effects of mutations in the ns proteins (and/or template RNAs); these studies can be extended
to the identification and characterization of host factors and mechanisms important for alpha-
virus replication. Finally, a trans-replication system can also be developed specifically to be
used in insect cells. Interestingly, constructs expressing short template RNAs for CHIKV repli-
case have been previously tested both in cultivated mosquito cells and in vivo [67]. However,
the amplification/transcription of the template RNA achieved using the previous system was
less than 20-fold, much less prominent compared to at least 103-fold amplification observed in
the current study (Fig 2). While it is possible that the low efficiency is a property of insect cells,
it is more likely that there is a lot of room for improvement in the insect cell-based system. If
the levels of RNA amplification/transcription can approach those seen in mammalian cells, it
would open a possibility for the development of efficient conditional expression systems for
insect cells and highly sensitive reporter cell lines.
The CHIKV trans-replicase represents a useful system for tagging of functional ns proteins
(Fig 4). Such trans-replicases, replicons and virus genomes represent valuable instruments for
studies of virus replication and virus-host interactions. Thus, ICRES-4SF (then named CHIKV
LR2006-OPY1-nsP4/FLAG) has already been used to visualize nsP4, which was not detectable
by nsP4-specific antibodies in CHIKV infected cells [8]. ICRES-4SF can also be used for analy-
sis of interactions between CHIKV nsP4 and cellular proteins as has been done for SINV [38].
CHIKV is clearly better suited for this analysis as individual nsP2 of CHIKV efficiently pro-
cesses the cleavage site in P34 polyprotein [6]. In contrast, at late stages of SINV infection P34
remains mostly uncleaved [68] making it difficult to distinguish whether identified host pro-
teins interact with individual nsP4 or with the nsP3 part of P34 polyprotein. Similarly, as RNA
genomes harboring EGFP tag in nsP1 are stable enough to allow experiments in cell culture,
host factors binding to nsP1 can be revealed by the same approach previously utilized to iden-
tify host proteins interacting with nsP2 [37] and nsP3 [36,58].
Finally, CHIKV trans-replication system can be applied for the development of antiviral
strategies. It has already been, to some extent, used for analyzing the molecular bases of attenu-
ation of CHIKV Δ5nsP3 virus [10], a highly efficient CHIKV vaccine candidate [69]. The
trans-replication system is also suitable for the discovery and subsequent analysis of inhibitors
affecting CHIKV replicase formation and function. Thus, with the T7 promoter-based version
of the system, it can be analyzed which exact step of RNA replication (negative strand, new
genomic RNA and/or SG RNA synthesis) is affected by the compounds. The trans-replicase
based assay would also simplify identification of the precise functions affected by different
inhibitors. For example, in the context of virus infection, the amounts of ns proteins (down-
regulated due to the overall suppression of viral RNA synthesis) may simply be too low to
enable detection of the effect of an inhibitor on e.g. ns polyprotein processing, or on the intra-
cellular localization of viral ns proteins. Uncoupling the replicase expression from RNA repli-
cation makes such assays feasible; the availability of mutant and tagged forms of trans-
replicase provides further advantages for such studies.
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